AzTrials
AzTrials

Hip-fractureREGENERATIONNCT07309575

Regional Versus General Anesthesia for Hip Fracture and Postoperative Oxygenation

An observational study of Hip-fracture and General Anaesthesia, run by University of Lisbon at 1 site in Portugal.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

With this study, the investigators intend to measure oxygen saturation before and after hip surgery in the context of proximal femur fracture, comparing two types of anesthesia (general or spinal). Read more about this study

Who is it for?
Ages 65 years and older
How many people
102 participants
Where
1 sitePortugal
Study dates
27 Nov 2025to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Elder subjects with hip-fracture submitted to surgery.

Who may be able to join

  • hospital admission for hip fracture;
  • scheduled for hip fracture surgery;
  • age above 65 years, both genders;
  • capable of consent or consent by responsible person;

Who cannot join

  • hip fracture during hospitalization (not present upon admission)
  • patient refusal to participate

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Portugal1 site, 1 recruiting
  • Northern Lisbon Hospital Center

    Lisbon, Lisbon District, 1635

    Andre dos Santos Rocha, MD, PhD, +351 969 345 052, andrerocha@medicina.ulisboa.pt

    Recruiting

Other trials in Portugal

About this study

With this study, the investigators intend to measure oxygen saturation before and after hip surgery in the context of proximal femur fracture, comparing two types of anesthesia (general or spinal). The investigators also intend to study the effects of the two anesthetic techniques on sleep apnea, delirium, respiratory complications, and length of hospital stay.

This is an observational study, in which oxygen is measured at the fingertip with a sensor and a bracelet, without any intervention, inconvenience, or discomfort for the participant. Data will be collected on: respiratory complications, sleep apnea, delirium, length of hospital stay, and survival.

Read more

Data will be collected in the operating room and wards of Santa Maria Hospital, Lisbon, Portugal over a period of approximately 24 hours after the participant's operation. Information about participant's health and co-morbidities will be recorded.

There will be no implication for the participants' clinical care, since the study measurements will not be sent to the health professionals in charge. The operation, recovery, and treatments will not be influenced at any time by participation in the study.

Read the detailed description

Frailty, comorbidities, medication (anticoagulants and anti-platellet agents) as well as acute and chronic illnesses have an impact on the choice of anesthesia strategy for hip fracture surgery. The choice between general anesthesia (GA) and loco-regional, spinal anesthesia (SA) may have impact on the postoperative period. Despite previous retrospective studies on this topic, it remains uncertain that either is superior in terms of post-operative outcomes, including mortality, delirium and respiratory complications, with conflicting results in the literature.

Postoperative pulmonary complications (PPC) are amongst the commonest complications in geriatric hip fractures, reported to be around 12%. The elder population at Hospital de Santa Maria (Tertiary University Hospital Center) receives the most challenging cases, with pilot data from the past 3 years (2022-2024, n=927) revealing an average risk score for PPC of 32,1%.

Considering that low oxygen saturation is an independent risk factor and a strong predictor for PPC, the investigators seek to compare the oxygenation during the perioperative period between the different anesthesia regimens.

The study hypothesis is that the anesthesia regimen (GA vs SA) has an impact on the oxygenation index during the first 24 postoperative hours.

The secondary objectives are to compare the sleep apnea index between GA and SA, the incidence of PPC, delirium, mortality and the length of stay (LOS) in the PACU and until discharge from the hospital.

Keywords
anaesthesia, hip femur fracture, postoperative pulmonary complications, oxygenation, sleep apnea
Medical subject headings
Hip Fractures, Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07309575
Study groupRoleWhat they receive
General anaesthesiaHip fracture surgery under general anaesthesia
Rregional anaesthesiaHip fracture surgery under regional anaesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxygenation index (SpO2/FiO2 ratio)

    Oxygenation index (SpO2/FiO2 ratio) measured as the difference between oxygenation index on admission to the operating room and the mean SpO2 during the next 24 postoperative hours, compared between groups.

    Peripheral oxygen saturation measured continuously during the first postoperative day with the Konica Minolta PULSOX-DS5® device.

    Measured: first postoperative day

Secondary outcomes (6)
  1. Sleep Apnea index

    average dips of SpO2 per hour, (>= 4%)

    Measured: first postoperative day

  2. Length of stay in the Post-anestesia Care Unit

    Length of stay in the Post-anestesia Care Unit

    Measured: after the surgery, at discharge from the Post-anestesia Care Unit

  3. Hospital Length of Stay (Days)

    Length of stay in the hospital from admission until discharge, in days

    Measured: from hospital admission to hospital discharge, approximatelly 5 days

  4. postoperative pulmonary complications

    postoperative pulmonary complications defined as hypoxemia, respiratory failure, atelectasis, pneumothorax, respiratory infection.

    Measured: during the first postoperative day

  5. Delirium

    Presence of delirium in the first postoperative day

    Measured: during the first postoperative day

  6. in-Hospital mortality

    death from any cause during hospital stay, from hospital admission to discharge

    Measured: From hospital admission to hospital discharge (or death), up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2025
  2. Study start27 Nov 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07309575
Sponsor's protocol ID
CE-CAML 221/25
Acronym
REGENERATION
Status last verified
Dec 2025
First submitted
27 Nov 2025
Last updated
30 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: only anonymised data can be shared after publication and upon reasonable request

Questions about this trial

What is this clinical trial studying?

An observational study of Hip-fracture and General Anaesthesia, run by University of Lisbon at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxygenation index (SpO2/FiO2 ratio) (time frame: first postoperative day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in